314 filings
Page 4 of 16
8-K
8cl1qoxe9 xbh
26 Sep 19
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
4:43pm
8-K
l5p3yqpro 2ig35
14 Aug 19
Precipio Announces Q2-2019 Corporate Update Call for Shareholders
12:00am
8-K
6844n
20 Jun 19
Precipio CEO Provides Update Letter To Shareholders
5:03pm
8-K
753pt wjz1564
19 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
bi7562 tkktm
10 Jun 19
Other Events
5:20pm
8-K
u0zxcjgwcux d5i
23 May 19
Other Events
4:38pm
8-K
eh0zcxlpr5mu w45
15 May 19
Other Events
4:08pm
8-K
ti6 rz7bgd9xx5n
26 Apr 19
Amendments to Articles of Incorporation or Bylaws
11:01am
8-K
7omkadaf4ue9t82x lta
26 Mar 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:13pm
8-K
1g7hy8iishqhhd4u73
11 Mar 19
Precipio CEO Issues Shareholder Update Letter
4:50pm
8-K
kprrzwhrfk42
14 Feb 19
Results of Operations and Financial Condition
12:00am
8-K
brr9au rxx8ts
30 Jan 19
Entry into a Material Definitive Agreement
5:20pm
8-K
n3yqbr cwe1l5
22 Jan 19
Unregistered Sales of Equity Securities
4:30pm
8-K
12exsfl ooyfb6yvaj
7 Jan 19
Entry into a Material Definitive Agreement
4:31pm
8-K
z0pbx 275q6uc0tr0pry
20 Dec 18
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
xglw7rzfwbljm9h
3 Dec 18
Entry into a Material Definitive Agreement
5:19pm
8-K
dop5wsf01vw7k
16 Nov 18
Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
4:47pm
8-K
fzqay4m6rlmi4za
16 Oct 18
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
4:41pm
8-K
p3xqa0viu1dw
27 Sep 18
Precipio Granted 180 Day NASDAQ Extension to Regain Compliance
12:00am
8-K
w8g02l1wj c7
25 Sep 18
Entry into a Material Definitive Agreement
12:00am